-
公开(公告)号:US07851498B2
公开(公告)日:2010-12-14
申请号:US11525573
申请日:2006-09-22
申请人: Mingde Xia , Fina Liotta , Huajun Lu , Meng Pan , Michael P. Wachter
发明人: Mingde Xia , Fina Liotta , Huajun Lu , Meng Pan , Michael P. Wachter
IPC分类号: A61K31/416 , C07D231/56
CPC分类号: C07D231/54 , C07D401/12 , C07D403/12
摘要: This invention is directed to a hexahydro-cyclooctyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
-
公开(公告)号:US07825151B2
公开(公告)日:2010-11-02
申请号:US11688589
申请日:2007-03-20
申请人: Mingde Xia , Fina Liotta , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
发明人: Mingde Xia , Fina Liotta , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
IPC分类号: A61K31/416 , C07D231/54
CPC分类号: C07D231/54 , C07D403/12
摘要: This invention is directed to a hexahydro-cyclooctyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的六氢 - 环辛基吡唑大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US20090197886A1
公开(公告)日:2009-08-06
申请号:US12419530
申请日:2009-04-07
申请人: Fina Liotta , Mingde Xia , Huajun Lu , Meng Pan , Michael P. Wachter
发明人: Fina Liotta , Mingde Xia , Huajun Lu , Meng Pan , Michael P. Wachter
IPC分类号: A61K31/416 , C07D231/54 , C07D413/12 , C07D401/12 , C07D403/12 , A61P25/00 , A61K31/454 , A61K31/5377 , A61K31/4439
CPC分类号: C07D231/54 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/06 , C07D403/12
摘要: This invention is directed to a hexahydro-cycloheptapyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的六氢 - 环庚三唑大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US08378117B2
公开(公告)日:2013-02-19
申请号:US11688552
申请日:2007-03-20
申请人: Fina Liotta , Mingde Xia , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
发明人: Fina Liotta , Mingde Xia , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
IPC分类号: C07D231/54
CPC分类号: C07D231/54 , C07D403/04
摘要: This invention is directed to a hexahydro-cycloheptapyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
-
公开(公告)号:US20100317633A1
公开(公告)日:2010-12-16
申请号:US12868812
申请日:2010-08-26
申请人: Mingde Xia , Fina Liotta , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
发明人: Mingde Xia , Fina Liotta , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
IPC分类号: A61K31/56 , A61K31/416 , A61K31/55 , A61K31/53 , A61K31/4166 , A61K31/57 , A61K31/519 , A61P15/18 , A61P25/08
CPC分类号: C07D231/54 , C07D403/12
摘要: This invention is directed to a hexahydro-cyclooctyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
-
公开(公告)号:US20080076814A1
公开(公告)日:2008-03-27
申请号:US11688589
申请日:2007-03-20
申请人: Mingde Xia , Fina Liotta , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
发明人: Mingde Xia , Fina Liotta , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
IPC分类号: A61K31/416 , A61P1/00 , A61P25/00 , A61P27/00 , A61P3/10 , C07D231/54
CPC分类号: C07D231/54 , C07D403/12
摘要: This invention is directed to a hexahydro-cyclooctyl pyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的六氢 - 环辛基吡唑大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US08378096B2
公开(公告)日:2013-02-19
申请号:US12419530
申请日:2009-04-07
申请人: Fina Liotta , Mingde Xia , Huajun Lu , Meng Pan , Michael P. Wachter
发明人: Fina Liotta , Mingde Xia , Huajun Lu , Meng Pan , Michael P. Wachter
IPC分类号: C07D413/12 , C07D231/54 , C07D401/12
CPC分类号: C07D231/54 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/06 , C07D403/12
摘要: This invention is directed to a hexahydro-cycloheptapyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的六氢 - 环庚三唑大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US20080070968A1
公开(公告)日:2008-03-20
申请号:US11688552
申请日:2007-03-20
申请人: Fina Liotta , Mingde Xia , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
发明人: Fina Liotta , Mingde Xia , Huajun Lu , Meng Pan , Michael P. Wachter , Mark J. Macielag
IPC分类号: A61K31/415 , A61P29/00 , C07D231/00
CPC分类号: C07D231/54 , C07D403/04
摘要: This invention is directed to a hexahydro-cycloheptapyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的六氢 - 环庚三唑大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US20100069341A1
公开(公告)日:2010-03-18
申请号:US12621724
申请日:2009-11-19
申请人: Fina Liotta , Huajun Lu , Michael P. Wachter , Mingde Xia
发明人: Fina Liotta , Huajun Lu , Michael P. Wachter , Mingde Xia
IPC分类号: A61K31/4162 , C07D491/052 , A61K31/454 , A61K31/4439 , A61P25/00 , A61P3/00 , A61K31/55 , A61K31/53 , A61K31/56
CPC分类号: C07D491/04
摘要: This invention is directed to a tetrahydro-pyranopyrazole cannabinoid modulator compound of formula (I): and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的四氢吡喃并吡唑大麻素调节剂化合物:以及用于治疗,改善或预防大麻素受体介导的综合征,病症或疾病的方法。
-
公开(公告)号:US07795294B2
公开(公告)日:2010-09-14
申请号:US11674210
申请日:2007-02-13
申请人: Fina Liotta , Huajun Lu , Michael P. Wachter , Mingde Xia
发明人: Fina Liotta , Huajun Lu , Michael P. Wachter , Mingde Xia
IPC分类号: A01N43/56 , C07D231/00 , C07D231/10 , C07D231/12
CPC分类号: C07D409/04 , C07D231/56 , C07D403/12
摘要: This invention is directed to a tetrahydro-2H-indazole pyrazole cannabinoid modulator compound of formula (I): or a form thereof, wherein p, R1, R2 and Ar are as herein described and * represents a chiral center, and a method for use in treating, ameliorating or preventing a cannabinoid receptor mediated syndrome, disorder or disease.
摘要翻译: 本发明涉及式(I)的四氢-2H-吲唑吡唑大麻素调节剂化合物或其形式,其中p,R 1,R 2和Ar如本文所述,*表示手性中心,以及使用的方法 治疗,改善或预防大麻素受体介导的综合征,病症或疾病。
-
-
-
-
-
-
-
-
-